Mutation in BRAF correlates with advanced stage, lymph node metastasis, extrathyroidal extension, as well as resistance to traditional radioiodine therapy in papillary thyroid cancer [9,10]. This evidence concerns the gene BRAF and thyroid gland papillary carcinoma.